Use access key #2 to skip to page content.
$32.15 1.52 (4.96%)
5/16/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar harrier26 (< 20) Submitted: 4/02/08 3:29 AM : Outperform Start Price: $31.63 AMLN Score: -2.29

This company has some of the most interesting and promising diabetes drugs in development.

Report this Post Replies: 0 | Reply

Featured Broker Partners